XML 43 R21.htm IDEA: XBRL DOCUMENT v3.21.2

Fair Value Measurements (Tables)

3 Months Ended

5 Months Ended

Mar. 31, 2021

Dec. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]

		Fair Value Measured as of March 31, 2021
		Level 1			Level 2			Level 3			Total
Assets:
Investments held in Trust Account		$	375,017,221		$	—		$	—		$	375,017,221
Liabilities:
Derivative warrant liabilities Public Warrants		$	23,394,190		$	—		$	—		$	23,394,190
Derivative warrant liabilities Private Warrants		$	—		$	—		$	12,730,000		$	12,730,000
Total fair value		$	398,411,411		$	—		$	12,730,000		$	411,141,411

		Fair Value Measured as of December 31, 2020
		Level 1			Level 2			Level 3			Total
Assets:
Investments held in Trust Account		$	375,007,974		$	—		$	—		$	375,007,974
Liabilities:
Derivative warrant liabilities Public Warrants		$	18,683,920		$	—		$	—		$	18,683,920
Derivative warrant liabilities Private Warrants					$	—		$	9,816,670		$	9,816,670
Total fair value		$	393,691,894		$	—		$	9,816,670		$	403,508,564

		Fair Value Measured as of December 31, 2020
		Level 1		Level 2		Level 3		Total
Liabilities:
Derivative warrant liabilities – Public Warrants (Restated)		$ 18,683,920		$ —		$ —		$18,683,920
Derivative warrant liabilities – Private Warrants (Restated)		$ —		$ —		$9,816,670		$9,816,670
Total fair value		$ 18,683,920		$ —		$ 9,816,670		$ 28,500,590

Fair Value, Concentration of Risk [Table Text Block]

		As of March 31, 2021				As of December 31, 2021
Exercise price		$	11.50			$	11.50
Stock Price		$	9.92			$	10.07
Option term (in years)			5.34				6.44
Volatility			29.10	%			21.00	%
Risk-free interest rate			1.00	%			0.57	%

		As of October 09, 2020			As of December 31, 2020
Exercise price		11.50			11.50
Stock Price		9.60			10.07
Option term (in years)		6.67			6.44
Volatility		19.8	%		21.0	%
Risk-free interest rate		0.52	%		0.57	%

Schedule of Derivative Liabilities at Fair Value [Table Text Block]

Warrant liabilities at January 1, 2021		$	9,816,670
Change in fair value of derivative warrant liabilities			2,913,330
Derivative warrant liabilities at March 31, 2021		$	12,730,00

Level 3 – Derivatrive warrant liabilities at July 29, 2020 (inception)		$	—
Level 3 – Derivatrive warrant liabilities at September 30, 2020			—
Issuance of Public and Private Warrants			23,041,670
Transfer to Level 1 measurement – Public Warrants			(18,683,920	)
Change in fair value of derivative warrant liabilities			5,458,920
Level 3 – Derivative warrant liabilities at December 31, 2020		$	9,816,670

X

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2C
-URI http://asc.fasb.org/extlink&oid=123874694&loc=SL7498348-110258

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of all significant concentrations of risk, including credit risk and market risk, arising from all financial instruments (as defined), whether from an individual counterparty or groups of counterparties. The disclosure concerning concentrations of risk may consist of the following information: (1) for concentrations of credit risk disclosure may include: (a) information about the (shared) activity, region, or economic characteristic that identifies the concentration, (b) the maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity, (c) the policy of requiring collateral or other security to support financial instruments subject to credit risk, information about the entity's access to that collateral or other security, and the nature and a brief description of the collateral or other security supporting those financial instruments, and (d) the policy of entering into master netting arrangements to mitigate the credit risk of financial instruments, information about the arrangements for which the entity is a party, and a brief description of the terms of those arrangements, including the extent to which they would reduce the entity's maximum amount of loss due to credit risk and (2) for disclosure of quantitative information about the market risks of financial instruments that is consistent with the way the company manages or adjusts those risks, disclosure may include: (a) more details about current positions and perhaps activity during the period, (b) the hypothetical effects on comprehensive income (or net assets), or annual income, of several possible changes in market prices, (c) a gap analysis of interest rate re-pricing or maturity dates, (d) the duration of the financial instruments, (e) the entity's value at risk from derivatives and from other positions at the end of the reporting period and the average value at risk during the year, or (f) other ways of reporting quantitative information as internally developed.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13572-108611

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 23
-URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13587-108611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611

+ Details

Name:	us-gaap_FairValueConcentrationOfRiskTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_FairValueDisclosuresAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of derivative liabilities at fair value.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration